. Author manuscript; available in PMC: 2021 Aug 1.

Published in final edited form as: Arthritis Rheumatol. 2020 Jul 20;72(8):1341–1349. doi: 10.1002/art.41265

Table 3.

Incidence of PH stratified by number of elevated vascular biomarkers measured at cohort entry. Increased number of elevated biomarkers associates with higher incidence of PH during follow-up (HR 1.78). With each increased in the number of biomarkers elevated at cohort entry, the risk of PH increases by 78%.

Number of Biomarkers at Baseline > Optimal Cutoff	PH Defined as mPAP≥21
Number of Biomarkers at Baseline > Optimal Cutoff	No (%)	Yes (%)	Total

0	23 (92)	2 (8)	25
1	59 (97)	2 (3)	61
2	73 (90)	8 (10)	81
3	53 (80)	13 (20)	66
4	29 (76)	9 (24)	38
5	17 (58)	12 (42)	29

Total	254	46	300